Home · Health · Aug 25 archive

Pro-life CEO predicts Trump FDA nominee could bring renewed scrutiny to abortion drug risks

Confirmed

Health Desk

"I think she's going to bring objectivity to the issue of mifepristone in a way that will expose this drug for the damage it causes women," Mize said in an interview on Friday, adding that his organization is "optimistic" that Overton will be a "pro-life FDA commissioner.

President Donald Trump, joined by, from left, National Institutes of Health Director Jay Bhattacharya, The Conservateur’s Jayme Leagh Franklin, Health and Human Services Secretary Robert F. John Mize, CEO of Americans United for Life (AUL), said he has had five or six conversations with Overton, who is known for her pro-life views.

Mize pointed to a 2025 study by the Ethics and Public Policy Center, a conservative think tank, that analyzed insurance claims from 865,727 mifepristone abortions between 2017 and 2023 and found a serious adverse event rate of nearly 11%.

Mize said he believes Overton is the "right candidate" to lead the FDA, citing her experience in government, clinical medicine and medical research. Having written thousands of songs across her decades-long career, Parton said songwriting was her greatest form of self-expression.

She has described the Opry as the "church of my heart" and said performing there was a lifelong dream.

What's confirmed

What's still developing

Sources